In vitro factor XI activation mechanism according to an optimized model of activated partial thromboplastin time test

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 4, 2001, Pages 289-299

  Kramoroff, A ^a   Nigretto, Jean Maxime ^a  

^a UNIVERSITÉ DE CERGY PONTOISE   (France)

Author keywords

Activated partial thromboplastin time; Coagulation kinetics; Intrinsic pathway; Plasma thromboplastin antecedent

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEPARIN; THROMBIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MATHEMATICAL MODEL; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

BLOOD COAGULATION; FACTOR XI; HUMANS; KINETICS; MODELS, BIOLOGICAL; PARTIAL THROMBOPLASTIN TIME;

EID: 0034974059     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200106000-00010     Document Type: Article

References (53)

1. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII)
2. Recent advances in the understanding of contact activation reactions
3. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate
4. Mechanism for the involvement of high molecular weight kininigen in surface-dependent reactions of Hageman factor
5. Interactions among Hageman factor, prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent
6. Mechanism of activation of bovine factor XI by factor XII and factor XIIa
7. Approach of the bleeding patient
8. Factor XI activation in a revised model of blood coagulation
9. Effect of glycosaminoglycans on factor XI activation by thrombin
10. Activation of human blood coagulation factor XI independent of factor XII
11. Activation of factor XI in plasma is dependent on factor XII
12. Fibrinogen blocks the auto-activation and thrombin-mediated activation of factor XI on dextran sulfate
13. FXIa induced activation of the intrinsic cascade in vivo
14. Thrombin-mediated activation of endogeneous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin
15. Activation of factor XI
16. Enzyme amplifier kinetics
17. Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy
18. Coagulation on biomaterials in flowing blood: Some theoretical considerations
19. An analysis of the contact phase of blood coagulation: Effects of shear rate and surface are intertwined
20. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. I. The model description
21. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results
22. Contact activation of blood coagulation: Trigger properties and hysteresis. Kinetic recognition of foreign surfaces upon contact activation of blood coagulation: A hypothesis
23. Approach of the bleeding patient
24. Mathematical model for the blood coagulation prothrombin time test
25. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes
26. Contact activation: A revision
27. Role of the contact system in fibrinolysis
28. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase
29. A comparison of the abilities of plasma kallikrein, beta-factor XIIa, factor XIa and urokinase to activate plasminogen
30. Contact activation pathway: Inflammation and coagulation
31. Initiation of coagulation and relationships between intrinsic and extrinsic coagulation pathways
32. Activation of human factor VII in plasma and in purified systems. Roles of activated factor IX, kallikrein and activated factor XII
33. Dissemination of contact activation in plasma by plasma kallikrein
34. Explicit constants for the dextran-sulfate-mediated activation and autoactivation of purified human factor XII (Hageman factor)
35. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII)
36. The role of phospholipid and factor VIIIa in the activation of bovine factor X
37. Role of human factor VIII in factor X activation
38. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism
39. The role of phospholipids and factor Va in the prothrombinase complex
40. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions
41. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: Role for antithrombin in the regulation of kallikrein
42. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen
43. The regulation of human factor XIIa by plasma proteinase inhibitors
44. Initiation mechanisms: The contact activation system in plasma
45. Kinetics of the factor XIa catalyzed activation of human blood coagulation factor IX
46. Kinetics of coagulation factor X activation by platelet-bound factor Ixa
47. Von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain
48. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin
49. Activation of human factor V by factor Xa and thrombin
50. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin
51. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin